30+ sources. Zero spin.
Cross-referenced, unbiased news. Both sides of every story.
American Missionary Dr. Peter Stafford Tests Positive for Ebola in DRC — U.S. Invokes Title 42, Seven Americans Being Evacuated to Germany

First American Infected
Dr. Peter Stafford, a Christian missionary physician working in the DRC, tested positive for Ebola late Sunday after developing symptoms over the weekend, according to the CDC. The international charity Serge identified him publicly. His wife, Dr. Rebekah Stafford, and at least one other physician were also exposed.
The CDC confirmed the positive test Monday during a press briefing led by Dr. Satish Pillai, the agency's Ebola response incident manager. The CDC and State Department are now working to evacuate Stafford and six other exposed Americans to Germany for treatment and monitoring.
No cases have been confirmed on U.S. soil. Pillai said the risk to the American public remains low.
U.S. Invokes Title 42
The same day the American case broke, the U.S. invoked Title 42 — a public health authority — to restrict entry for non-U.S. passport holders who have been in the DRC, South Sudan, or Uganda within the past three weeks. The restriction runs for 30 days.
The Washington Post reported the U.S. is also screening travelers at airports. Border screening and entry restrictions exist for moments like this.
The Numbers Are Getting Worse
As of Tuesday, 131 people are confirmed dead and more than 513 cases are suspected in the DRC, according to DRC Health Minister Dr. Samuel Roger Kamba. WHO Director-General Dr. Tedros Adhanom Ghebreyesus confirmed 30 cases in the remote northeastern Ituri province alone.
One person has also died in neighboring Uganda.
Those numbers may be incomplete. Modeling released Monday by the MRC Centre for Global Infectious Disease Analysis in London concluded there has been "substantial" under-detection. The study said it could NOT rule out that more than 1,000 cases have already occurred. The true scale of the outbreak, per the researchers, "remains uncertain."
WHO's Dr. Anne Ancia told the BBC that the more investigators look, the more they find cases have spread to areas beyond the known epicenter. WHO has said the outbreak is spreading "faster than first thought," and it made that assessment after already declaring a global health emergency.
The Strain Is the Problem
This outbreak is driven by the Bundibugyo strain — one of six known Orthoebolaviruses that cause Ebola disease. There is no approved vaccine and no approved treatment for Bundibugyo.
The vaccines that exist — and that worked during the 2014-2016 West Africa crisis — were developed for the Ebola Zaire strain. They don't apply here.
Historically, Bundibugyo kills between 25% and 50% of those infected, according to the CDC. With 513+ suspected cases and 131 confirmed dead, the current case fatality rate is tracking at roughly 25%.
Understanding the Gaps
The modeling issue is significant. The MRC study isn't a fringe estimate. It's a peer-reviewed epidemiological model saying we may already be at 1,000+ cases while official counts say 513. That's a nearly 2x under-count. Contact tracing depends on knowing who is infected.
The vaccine gap reflects how research priorities shifted after 2014. The scientific and global health community largely focused resources on Zaire-strain vaccines. Bundibugyo was considered rare enough not to prioritize.
The New York Times reported the outbreak "could last months" — a key detail given the vaccine shortage.
What This Means in the U.S.
The CDC's Pillai said risk to the American public is low. Ebola spreads through direct contact with bodily fluids, not through the air. It's not airborne. Casual contact doesn't transmit it.
Dr. Stafford got it doing exactly what American missionaries and aid workers do every day. Six other Americans are now in the exposure window. The evacuation to Germany indicates the U.S. is treating this seriously.
The 30-day Title 42 restriction on non-citizens from three countries is a targeted measure. It should have come the day WHO declared the PHEIC. The key question now is whether the MRC's modeling of 1,000+ true cases gets confirmed by the data over the next two weeks.